Analyst Wire — 2026-11-12
Every US sell-side action recorded on 2026-11-12 — 52 in total: 2 upgrades, 9 downgrades, plus initiations and price-target moves, frozen as recorded.
The live wire refreshes through each trading day; this page never changes again. Third-party actions with our context — a diary, not advice.
Upgrades (2)
| Name | Firm | Rating | Target | Call | Ours |
|---|---|---|---|---|---|
| AMD | William Blair | Market Perform → Outperform | — | Upgraded to Outperform from Market Perform | Rubin |
| MPB | Raymond James | Outperform → Strong Buy | — | Upgraded to Strong Buy from Outperform | — |
Downgrades (9)
| Name | Firm | Rating | Target | Call | Ours |
|---|---|---|---|---|---|
| AMD | KeyBanc | Overweight → Sector Weight | — | Downgraded to Sector Weight from Overweight | Rubin |
| AMD | Bernstein | Outperform → Market Perform | — | Downgraded to Market Perform from Outperform | Rubin |
| AMD | Citigroup | Buy → Underperform | — | Downgraded to Underperform from Buy | Rubin |
| AMD | Piper Sandler | Overweight → Neutral | — | Downgraded to Neutral from Overweight | Rubin |
| NVDA | KeyBanc | Overweight → Sector Weight | — | Downgraded to Sector Weight from Overweight | Rubin · AW40 |
| IHRT | Bank of America Securities | Neutral → Underperform | — | Downgraded to Underperform from Neutral | — |
| NVDA | William Blair | Underweight → Market Perform | — | Downgraded to Market Perform from Underweight | Rubin · AW40 |
| SW | Goldman Sachs | Neutral → Sell | — | Downgraded to Sell from Neutral | — |
| NVDA | Oppenheimer | Outperform → Perform | — | Downgraded to Perform from Outperform | Rubin · AW40 |
Initiations (11)
| Name | Firm | Rating | Target | Call | Ours |
|---|---|---|---|---|---|
| CSCO | Deutsche Bank | Buy → Buy | — | Initiated to Buy from Buy | — |
| CSCO | Bernstein | Market Perform → Market Perform | — | Initiated to Market Perform from Market Perform | — |
| AMD | BTIG | Buy → Buy | — | Initiated to Buy from Buy | Rubin |
| AMD | H.C. Wainwright | Buy | — | Initiated to Buy | Rubin |
| AMD | Roth Capital | Buy → Buy | — | Initiated to Buy from Buy | Rubin |
| AMD | Barclays | Underweight → Overweight | — | Initiated to Overweight from Underweight | Rubin |
| DORM | Barclays | Overweight | — | Initiated to Overweight | — |
| MBX | H.C. Wainwright | Buy | — | Initiated to Buy | — |
| SP | Jefferies | Hold | — | Initiated to Hold | — |
| QNT | BTIG | Buy | — | Initiated to Buy | — |
| ENSC | UBS | Buy | — | Initiated to Buy | — |
Price-target moves (30)
| Name | Firm | Rating | Target | Call | Ours |
|---|---|---|---|---|---|
| TWST | Jefferies | — | $125 | Target set to $125 (+9.4% to spot) | — |
| SPIR | Canaccord | — | $21.5 | Target set to $21.5 (+131.7% to spot) | — |
| MXCT | Buy by Stifel After Solid Quarter | — | $4 | Target set to $4 (+236.5% to spot) | — |
| ATRC | Buy by Stifel After Healthcare Conference | — | $70 | Target set to $70 (+23.5% to spot) | — |
| GO | DA Davidson | — | $14 | Target set to $14 (+8.6% to spot) | — |
| RSKD | DA Davidson | — | $12 | Target set to $12 (+22.2% to spot) | — |
| EMR | DA Davidson | — | $160 | Target set to $160 (-5.7% to spot) | — |
| GILD | Argus | — | $190 | Target set to $190 (+12.4% to spot) | — |
| W | Argus | — | $135 | Target set to $135 (+20.3% to spot) | — |
| ALC | Bernstein SocGen Group | — | $88.9 | Target set to $88.9 (+22.1% to spot) | — |
| CAH | Argus | — | $309 | Target set to $309 (+11.5% to spot) | — |
| AMGN | Argus | — | $515 | Target set to $515 (+9.3% to spot) | HALO |
| CRWV | Argus | — | $100 | Target set to $100 (+81.7% to spot) | AEI |
| RDDT | Argus | — | $150 | Target set to $150 (+51.1% to spot) | AW40 |
| ACOG | Raymond James | — | $21 | Target set to $21 (+139.5% to spot) | — |
| JLL | Jefferies | — | $438 | Target set to $438 (+18.9% to spot) | — |
| DDI | Wedbush | — | $16.25 | Target set to $16.25 (+3.4% to spot) | — |
| BUR | Wedbush | — | $3.25 | Target set to $3.25 (-11% to spot) | — |
| FIS | Truist Securities | — | $31 | Target set to $31 (+2.6% to spot) | — |
| FOUR | Truist Securities | — | $43 | Target set to $43 (-1.3% to spot) | — |
| AVEX | Needham | — | $30 | Target set to $30 (+147.3% to spot) | — |
| MYGN | Stephens | — | $6 | Target set to $6 (+4.9% to spot) | — |
| BGSI | Mizuho | — | $115 | Target set to $115 (+49% to spot) | — |
| WBI | Wells Fargo | — | $31 | Target set to $31 (+10.8% to spot) | — |
| MLM | UBS | — | $640 | Target set to $640 (+22.1% to spot) | — |
| FROG | Morgan Stanley | — | $114 | Target set to $114 (+4.1% to spot) | AEI |
| NVDA | RBC Capital | — | $230 | Target set to $230 (+32.4% to spot) | Rubin · AW40 |
| RCL | BofA Securities | — | $365 | Target set to $365 (+8.9% to spot) | — |
| RKLB | Berenberg | — | $85 | Target set to $85 (+28.5% to spot) | HALO |
| NVDA | Stifel | — | $205 | Target set to $205 (+18% to spot) | Rubin · AW40 |
AI-generated — produced automatically by Closelooknet’s systems under this site’s editorial policy.